Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Interest Expenses (2023 - 2025)

Immunocore Holdings (IMCR) has disclosed Interest Expenses for 3 consecutive years, with $3.1 million as the latest value for Q4 2025.

  • Quarterly Interest Expenses fell 56.62% to $3.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.2 million through Dec 2025, down 35.44% year-over-year, with the annual reading at $12.2 million for FY2025, 35.44% down from the prior year.
  • Interest Expenses hit $3.1 million in Q4 2025 for Immunocore Holdings, roughly flat from $3.0 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $7.0 million in Q4 2024 to a low of $1.2 million in Q1 2023.
  • Historically, Interest Expenses has averaged $3.0 million across 3 years, with a median of $3.0 million in 2025.
  • Biggest five-year swings in Interest Expenses: surged 437.66% in 2024 and later tumbled 56.62% in 2025.
  • Year by year, Interest Expenses stood at $1.3 million in 2023, then soared by 437.66% to $7.0 million in 2024, then crashed by 56.62% to $3.1 million in 2025.
  • Business Quant data shows Interest Expenses for IMCR at $3.1 million in Q4 2025, $3.0 million in Q3 2025, and $3.0 million in Q2 2025.